These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Podrid PJ; Fuchs T; Candinas R Circulation; 1990 Aug; 82(2 Suppl):I103-13. PubMed ID: 1973640 [TBL] [Abstract][Full Text] [Related]
23. Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology. Mason DT; DeMaria AN; Amsterdam EA; Zelis R; Massumi RA Drugs; 1973; 5(4):261-91. PubMed ID: 4146767 [No Abstract] [Full Text] [Related]
24. [Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects]. Popov VV; Kopitsa NP; Oparin AL Klin Med (Mosk); 1998; 76(2):15-9. PubMed ID: 9553353 [No Abstract] [Full Text] [Related]
28. Clinical pharmacology of antiarrhythmic agents. Kelliher GJ; Kowey P; Engel T; Wetstein L Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883 [No Abstract] [Full Text] [Related]
29. New drugs for the treatment of cardiac arrhythmias. Bump TE; Arnsdorf MF Compr Ther; 1980 Jun; 6(6):63-72. PubMed ID: 6103779 [No Abstract] [Full Text] [Related]
30. [The role of beta-blocking agents in the treatment of cardiac dysrhythmia (author's transl)]. Clémenty J; Dallocchio M; Lévy S; Bricaud H Ann Cardiol Angeiol (Paris); 1976 Dec; 25(6):535-42. PubMed ID: 13701 [No Abstract] [Full Text] [Related]
31. Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular arrhythmias. Singh BN; Nademanee K Am Heart J; 1987 Oct; 114(4 Pt 2):1040-50. PubMed ID: 2444089 [No Abstract] [Full Text] [Related]